Syneos Health joins CMPP

Published: Tuesday 07 September 2021 by CMPP

September 2021

Syneos Health Joins the Community Matters Partnership Project

CMPP is delighted to announce that global healthcare company, Syneos Health®, has joined as a Business Partner. Syneos Health is a leading biopharmaceutical solutions provider, purpose built to create greater success for their customers. At Syneos Health, clinical and commercial work in concert, sharing insights and knowledge that can develop better, smarter, faster ways to bring biopharmaceutical products to market.

With offices all around the world, Syneos Health emphasises five key attributes of its culture: collaboration, accountability, trust, innovation and professional advancement for their approximately 27,000 staff. These cultural attributes inspire their corporate value. 

Kerry Utton, Head of Syneos Health Farnborough Office, commented, “Since moving to the Farnborough Business Park (FBP) in 2018, we’ve been steadily increasing our involvement in the local community, mainly via FBP-led events. Joining CMPP as a Business Partner is a perfect way for us to be even more proactive, particularly considering the impact the pandemic has had on fundraising and charitable activities. We chose to partner with CMPP because their model provides our employees with a variety of ways to engage and participate. It’s very inclusive, which aligns beautifully with our company ethos and values.”

 Paul Marcus, Chief Operating Officer at CMPP, added, “We are thrilled that Syneos Health has joined our project. They have a strong sense of commitment to the communities in which they operate, and we look forward to helping them make more connections and support interesting and worthwhile projects with schools and charities in the local area.”

About Syneos Health

Syneos Health® is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. We bring together approximately 27,000 clinical and commercial minds to help our biopharmaceutical customers shorten the distance from lab to life. Learn more at